search
Back to results

Evaluation of the Distortion Correction Data Collection (DCDC) App Software

Primary Purpose

Age-related Macular Degeneration

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
DCDC App
Sponsored by
University of Nebraska
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Age-related Macular Degeneration

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 55 years of age or greater
  • Diagnosed with age-related macular degeneration (AMD).
  • Best corrected visual acuity (BCVA) of (20/40 to 20/200 Snellen equivalent).
  • Visual distortion is present in at least one eye, as determined by Amsler grid evaluation.
  • Have had the following imaging tests completed within the past three months as part of standard of care: optical coherence tomography (OCT), scanning laser ophthalmoscopy (SLO), and Fluorescein angiography (FA).
  • Capable of understanding the requirements of the study, willing to follow study instructions, able to provide written informed consent to participate, and willing to comply with all study requirements.
  • Women who are post-menopausal or not otherwise of child-bearing potential -

Exclusion Criteria:

  • Visual field loss from diseases other than AMD.
  • Visual distortions from the following conditions other than AMD: epiretinal membrane, diabetic macular edema, central retinal vein occlusion (CRVO) with edema, and cystoid macular edema.
  • A medical condition, serious concurrent illness, or extenuating circumstance that would significantly decrease ability to follow study instructions.

Sites / Locations

  • University of Nebraska Medical Center, Truhlsen Eye Institute

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

DCDC app

Arm Description

Subjects will evaluate the DCDC app

Outcomes

Primary Outcome Measures

Functionality of the Distortion Correction Data Collection App (DCDC), as measured by successful usage of the app by subjects.
Subjects will use the app to trace visual distortions. The app will correct these distortions, subjects will give feedback on these corrections. Test will be repeated two times.

Secondary Outcome Measures

Full Information

First Posted
December 17, 2014
Last Updated
August 31, 2023
Sponsor
University of Nebraska
search

1. Study Identification

Unique Protocol Identification Number
NCT02337647
Brief Title
Evaluation of the Distortion Correction Data Collection (DCDC) App Software
Official Title
Evaluation of the Distortion Correction Data Collection (DCDC) App Software to Repair Visual Distortions for Low Vision Age-related Macular Degeneration, and the Correlation of the Distortions With Clinical Examination
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
December 29, 2014 (Actual)
Primary Completion Date
March 1, 2016 (Actual)
Study Completion Date
June 1, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nebraska

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the research study is to evaluate how well the Distortion Correction Data Collection (DCDC) App works. The DCDC App is an experimental software application that is being developed at the University of Nebraska Omaha. The DCDC app will map and draw the visual distortions of patients with Age-related Macular degeneration.
Detailed Description
This research study is a phase 1 clinical trial to evaluate the efficacy of the Distortion Correction Data Collection (DCDC) App on a computer tablet system. There are two objectives in this study. The primary objective is to evaluate the functionality of the visual distortion app on the tablet computer. Patients will draw their distortions on the tablet screen, and the app will record and correct the distortions.The second objective is to create a distortion data repository (DDR) that contains retinal maps, data pertaining to the anatomical and functional aspects of patients retinas and the distortions. This DDR will be used to correlate retinal health to distortions.The correlation will be key in improving the correction software of the app. Long term, the app will be used to create a diagnostic tool and improve image processing in retinal prosthesis systems. Participating subjects must be at least 55 years of age or older with age-related macular degeneration (AMD). After consent, a chart review will be performed. At the baseline visit, subjects will have an electroretinogram (ERG). At the single study visit, to be scheduled within 2 weeks of the baseline visit, subjects will use the DCDC app on a tablet computer to trace their visual distortions on an Amsler grid. Up to 5 subjects who meet the inclusion/exclusion criteria will be enrolled. The duration of the study is a 2 hour baseline visit and a 1 hour study visit, all within 2 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Age-related Macular Degeneration

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DCDC app
Arm Type
Other
Arm Description
Subjects will evaluate the DCDC app
Intervention Type
Other
Intervention Name(s)
DCDC App
Intervention Description
The DCDC app is an experimental software that allows users to map their visual distortions on a tablet computer.
Primary Outcome Measure Information:
Title
Functionality of the Distortion Correction Data Collection App (DCDC), as measured by successful usage of the app by subjects.
Description
Subjects will use the app to trace visual distortions. The app will correct these distortions, subjects will give feedback on these corrections. Test will be repeated two times.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 55 years of age or greater Diagnosed with age-related macular degeneration (AMD). Best corrected visual acuity (BCVA) of (20/40 to 20/200 Snellen equivalent). Visual distortion is present in at least one eye, as determined by Amsler grid evaluation. Have had the following imaging tests completed within the past three months as part of standard of care: optical coherence tomography (OCT), scanning laser ophthalmoscopy (SLO), and Fluorescein angiography (FA). Capable of understanding the requirements of the study, willing to follow study instructions, able to provide written informed consent to participate, and willing to comply with all study requirements. Women who are post-menopausal or not otherwise of child-bearing potential - Exclusion Criteria: Visual field loss from diseases other than AMD. Visual distortions from the following conditions other than AMD: epiretinal membrane, diabetic macular edema, central retinal vein occlusion (CRVO) with edema, and cystoid macular edema. A medical condition, serious concurrent illness, or extenuating circumstance that would significantly decrease ability to follow study instructions.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vikas Gulati, MD
Organizational Affiliation
University of Nebraska
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Nebraska Medical Center, Truhlsen Eye Institute
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198-5540
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Distortion Correction Data Collection (DCDC) App Software

We'll reach out to this number within 24 hrs